Artal Group S.A. Scholar Rock Holding Corp Put Options Transaction History
Artal Group S.A.
- $1.86 Billion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding SRRK
# of Institutions
165Shares Held
73.6MCall Options Held
501KPut Options Held
26.3K-
Price T Rowe Associates Inc Baltimore, MD8.21MShares$63.8 Million0.02% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$52.7 Million38.03% of portfolio
-
Redmile Group, LLC San Francisco, CA6.42MShares$49.9 Million4.49% of portfolio
-
Black Rock Inc. New York, NY5.01MShares$38.9 Million0.0% of portfolio
-
State Street Corp Boston, MA4.17MShares$32.4 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $401M
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...